×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder
Become an Incathlab member and receive full access to its content!
You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.
Registration Login
Registration Login
Clinical Data
- Patient: Male, 54 years old
- 2005 CTO PCI of the RCA with DES
- 2011 CTO PCI of the LAD with DES
- Asymptomatic for several years
- No concomitant diseases known
- CVRF: former smoker (10py), hypertension, dyslipidemia, IDDM
- Echo: LVEF 65%, normal
- MRI: Normal LVEF, full viability, large inferior ischemia
- Renal function: eGFR = 93 ml/min/1.73m2
- Since 3 month angina pectoris CCS II
- SPECT with inferior ischemia. Sent for CAG
- CAG 5.9.17: LAD 50% with good result in DES, CX without stenosis, in-stent reocclusion of the RCA
- J-CTO score: 1
Shooting date : 2017-09-13
Last update : 2017-10-31
Last update : 2017-10-31
Cruiser / Teleflex (BIOTRONIK Vascular Intervenion)
Coronary Guide Wire Indicated for PTCA applications
SeQuent® Please NEO / B. Braun
Next generation coronary Drug Coated Balloon to treat vascular stenosis
OptiRAY® / Guerbet
Optiray® contrast agent is lower osmolar, lower viscosity and nonionic.
Suggestions
Saturday, November 8th 2025 from 01:30pm to 02:15pm (GMT+1)
Honolulu : Saturday, November 8th 2025 from 02:30am to 03:15am (GMT+1)
San Francisco : Saturday, November 8th 2025 from 04:30am to 05:15am (GMT+1)
New York : Saturday, November 8th 2025 from 07:30am to 08:15am (GMT+1)
Buenos Aires : Saturday, November 8th 2025 from 09:30am to 10:15am (GMT+1)
London / Dublin : Saturday, November 8th 2025 from 12:30pm to 01:15pm (GMT+1)
Paris / Berlin : Saturday, November 8th 2025 from 01:30pm to 02:15pm (GMT+1)
Istanbul : Saturday, November 8th 2025 from 02:30pm to 03:15pm (GMT+1)
Moscou / Dubaï : Saturday, November 8th 2025 from 04:30pm to 05:15pm (GMT+1)
Bangkok : Saturday, November 8th 2025 from 07:30pm to 08:15pm (GMT+1)
Shanghai : Saturday, November 8th 2025 from 08:30pm to 09:15pm (GMT+1)
Tokyo : Saturday, November 8th 2025 from 09:30pm to 10:15pm (GMT+1)
Sydney : Saturday, November 8th 2025 from 10:30pm to 11:15pm (GMT+1)
Wellington : Sunday, November 9th 2025 from 12:30am to 01:15am (GMT+1)
San Francisco : Saturday, November 8th 2025 from 04:30am to 05:15am (GMT+1)
New York : Saturday, November 8th 2025 from 07:30am to 08:15am (GMT+1)
Buenos Aires : Saturday, November 8th 2025 from 09:30am to 10:15am (GMT+1)
London / Dublin : Saturday, November 8th 2025 from 12:30pm to 01:15pm (GMT+1)
Paris / Berlin : Saturday, November 8th 2025 from 01:30pm to 02:15pm (GMT+1)
Istanbul : Saturday, November 8th 2025 from 02:30pm to 03:15pm (GMT+1)
Moscou / Dubaï : Saturday, November 8th 2025 from 04:30pm to 05:15pm (GMT+1)
Bangkok : Saturday, November 8th 2025 from 07:30pm to 08:15pm (GMT+1)
Shanghai : Saturday, November 8th 2025 from 08:30pm to 09:15pm (GMT+1)
Tokyo : Saturday, November 8th 2025 from 09:30pm to 10:15pm (GMT+1)
Sydney : Saturday, November 8th 2025 from 10:30pm to 11:15pm (GMT+1)
Wellington : Sunday, November 9th 2025 from 12:30am to 01:15am (GMT+1)
SELUTION DeNovo 1-year data – New data = New perspectives?
What do the SELUTION DeNovo 1-year results mean for clinical practice in Germany?
Share
Thursday, September 14th 2017 from 01pm to 02:30pm (GMT+2)
Honolulu : Thursday, September 14th 2017 from 02am to 03:30am (GMT+2)
San Francisco : Thursday, September 14th 2017 from 05am to 06:30am (GMT+2)
New York : Thursday, September 14th 2017 from 08am to 09:30am (GMT+2)
Buenos Aires : Thursday, September 14th 2017 from 09am to 10:30am (GMT+2)
Reykjavik : Thursday, September 14th 2017 from 12pm to 01:30pm (GMT+2)
London / Dublin : Thursday, September 14th 2017 from 01pm to 02:30pm (GMT+2)
Paris / Berlin : Thursday, September 14th 2017 from 02pm to 03:30pm (GMT+2)
Istanbul : Thursday, September 14th 2017 from 03pm to 04:30pm (GMT+2)
Moscou / Dubaï : Thursday, September 14th 2017 from 04pm to 05:30pm (GMT+2)
Bangkok : Thursday, September 14th 2017 from 07pm to 08:30pm (GMT+2)
Shanghai : Thursday, September 14th 2017 from 08pm to 09:30pm (GMT+2)
Tokyo : Thursday, September 14th 2017 from 09pm to 10:30pm (GMT+2)
Sydney : Thursday, September 14th 2017 from 11pm to 12:30am (GMT+2)
Wellington : Friday, September 15th 2017 from 01am to 02:30am (GMT+2)
San Francisco : Thursday, September 14th 2017 from 05am to 06:30am (GMT+2)
New York : Thursday, September 14th 2017 from 08am to 09:30am (GMT+2)
Buenos Aires : Thursday, September 14th 2017 from 09am to 10:30am (GMT+2)
Reykjavik : Thursday, September 14th 2017 from 12pm to 01:30pm (GMT+2)
London / Dublin : Thursday, September 14th 2017 from 01pm to 02:30pm (GMT+2)
Paris / Berlin : Thursday, September 14th 2017 from 02pm to 03:30pm (GMT+2)
Istanbul : Thursday, September 14th 2017 from 03pm to 04:30pm (GMT+2)
Moscou / Dubaï : Thursday, September 14th 2017 from 04pm to 05:30pm (GMT+2)
Bangkok : Thursday, September 14th 2017 from 07pm to 08:30pm (GMT+2)
Shanghai : Thursday, September 14th 2017 from 08pm to 09:30pm (GMT+2)
Tokyo : Thursday, September 14th 2017 from 09pm to 10:30pm (GMT+2)
Sydney : Thursday, September 14th 2017 from 11pm to 12:30am (GMT+2)
Wellington : Friday, September 15th 2017 from 01am to 02:30am (GMT+2)
How should I treat complex anatomic lesions and manage complications?
Interactive discussion with your experts - Rotablator & CTO
Share
